Observational studyCardiovascular diabetology2026
Dynamic association between triglyceride-glucose-body mass index and hospital mortality in critically ill patients with heart failure: a multicenter retrospective cohort study.
Observational study in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe triglyceride-glucose-body mass index (TYG-BMI) is a surrogate marker of insulin resistance associated with cardiovascular outcomes in stable populations. However, its physiological meaning in critically ill patients-where glucose and triglyceride levels are influenced by acute stress, inflammation, and treatment-remains uncertain, and the dynamic relationship between TYG-BMI and mortality in critically ill heart failure (HF) patients has not been investigated.
objectivesTo examine the association between TYG-BMI intensity, exposure duration, and hospital mortality in critically ill HF patients, and to evaluate the robustness of these associations through comprehensive sensitivity analyses.
methodsThis multicenter retrospective study analyzed data from MIMIC-III, MIMIC-IV, and eICU databases. Adult HF patients with daily TYG-BMI measurements during the 7 day observation period (day 0 through day 7) were included. Restricted cubic spline regression characterized the baseline dose-response relationship. Generalized additive models with tensor product smooth functions examined the three-dimensional TYG-BMI-time-mortality association. Weighted linear regression quantified temporal trends. Multiple sensitivity analyses addressed selection bias, time-varying confounding, treatment effect modification, and temporal heterogeneity.
resultsAmong 5133 patients (pooled mortality: 27.9%), restricted cubic spline analysis confirmed a non-linear U-shaped dose-response relationship in MIMIC-IV (non-linear P < 0.001), with consistent directional patterns across MIMIC-III and eICU. Generalized additive models demonstrated a reproducible U-shaped association across all three databases. The optimal TYG-BMI range was 250-275 (OR = 0.76, 95% CI 0.68-0.85, P < 0.001 in MIMIC-IV), with each additional day within this range reducing mortality risk by 0.4% (P < 0.01). TYG-BMI > 425 was associated with progressively increased mortality (OR = 1.61, 95% CI 1.35-1.93 for the 425-450 range), with time-dependent risk amplification reaching 2.5% per day at the highest stratum. Combining TYG-BMI with the SOFA score significantly improved discriminative performance beyond SOFA alone (AUC: 0.780 versus 0.720, DeLong P < 0.001). All sensitivity analyses yielded consistent findings.
conclusionsTYG-BMI demonstrates a reproducible, U-shaped association with hospital mortality in critically ill HF patients. Both intensity and exposure duration contribute to risk stratification, though prospective validation is warranted given the observational design and uncertain physiological specificity of TYG-BMI in the ICU setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.